Eric King

Biofourmis brings the right care to every person, no matter where they are. The company’s AI-driven solution collects and analyzes over 120 biomarkers in real time and identifies shifts that require proactive interventions. This vital innovation enables Biofourmis to offer people everywhere connected access to hospital-level services, virtual provider networks for remote care, and life-changing clinical trials—all without leaving their homes. Trusted by leading health systems, payers, biopharma companies and patients alike, Biofourmis’ connected platform improves patient outcomes, prevents hospitalization readmissions, accelerates drug development, and closes critical gaps in care—with the goal of making science smarter, healthcare simpler, and patients healthier. Biofourmis is a global technology company enabling care delivery, with headquarters in Boston with key offices in Singapore and India. For more information, visit biofourmis.com and follow Biofourmis on LinkedIn, Twitter and YouTube.

At Caresyntax, we are dedicated to making surgery safer and smarter. Our mission is to converge AI-powered software, devices, and clinical services to help our customers improve surgical outcomes. Our platform, an enterprise-grade surgical intelligence system, is vendor-neutral and equipped with proprietary software, hardware, and advanced AI capabilities. It can ingest and analyze data throughout the surgical workflow, including EMR, video, audio, image, device data, financial and outcomes data, and clinical and operational metrics to capture a complete picture of the surgical pathway. The platform generates insights across the entire continuum of care—before the procedure with surgical workflow optimization, during surgery with real-time clinically relevant support tools, and post procedure with clinical safety modules. The platform also produces data analytics and insights for medical device companies, insurers, and other ecosystem players to innovate and drive the future of healthcare delivery. Headquartered in the US in San Francisco and internationally in Berlin, Caresyntax software is used in over 4,200 ORs globally and aids surgical teams in over 3 million procedures annually. To learn more about how we’re transforming surgical care, visit us at www.caresyntax.com.

Intel Capital is a force multiplier for early-stage startups - inspiring and investing in the future of compute via investments in Cloud, Silicon, Devices, and Frontier.

GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our services – News & Analysis, Community & Events, and the GCV Institute – we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources. News and Analysis We cover the companies, deals, people, and emerging investment trends shaping the future of innovation and capital. Through our website, newsletter, social channels and reports, we provide corporate investors with the critical insights and best practices they need to develop and succeed. Community and Events We curate influential executive forums, events and industry sector councils where leaders of the global corporate venturing community and their ecosystems connect, share best practices and plan for success in a constantly changing world. GCV Institute The Institute unleashes the collective power of corporations as strategic investors and innovation partners. It supports the industry with professional development and certification informed by GCV Keystones unique operational benchmarking. By CVCs for CVCs, the Institute convenes powerful communities of practice. GCV Leadership Society The Leadership Society is comprised of CVCs from across the globe who recognise the individual and collective benefits of coming together to form a community that advances the industry in impactful ways. Members benefit from the full range of GCV services that enable them to successfully navigate today’s innovation and investment landscape. Get in Touch As a team we are passionate about delivering maximum value to our clients and we would value the opportunity to discuss your needs in greater detail. Please get in touch to discuss where we and our community can best support you.

At Solventum, we enable better, smarter, safer healthcare to improve lives. We never stop solving for you.

Biofourmis brings the right care to every person, no matter where they are. The company’s AI-driven solution collects and analyzes over 120 biomarkers in real time and identifies shifts that require proactive interventions. This vital innovation enables Biofourmis to offer people everywhere connected access to hospital-level services, virtual provider networks for remote care, and life-changing clinical trials—all without leaving their homes. Trusted by leading health systems, payers, biopharma companies and patients alike, Biofourmis’ connected platform improves patient outcomes, prevents hospitalization readmissions, accelerates drug development, and closes critical gaps in care—with the goal of making science smarter, healthcare simpler, and patients healthier. Biofourmis is a global technology company enabling care delivery, with headquarters in Boston with key offices in Singapore and India. For more information, visit biofourmis.com and follow Biofourmis on LinkedIn, Twitter and YouTube.

At Caresyntax, we are dedicated to making surgery safer and smarter. Our mission is to converge AI-powered software, devices, and clinical services to help our customers improve surgical outcomes. Our platform, an enterprise-grade surgical intelligence system, is vendor-neutral and equipped with proprietary software, hardware, and advanced AI capabilities. It can ingest and analyze data throughout the surgical workflow, including EMR, video, audio, image, device data, financial and outcomes data, and clinical and operational metrics to capture a complete picture of the surgical pathway. The platform generates insights across the entire continuum of care—before the procedure with surgical workflow optimization, during surgery with real-time clinically relevant support tools, and post procedure with clinical safety modules. The platform also produces data analytics and insights for medical device companies, insurers, and other ecosystem players to innovate and drive the future of healthcare delivery. Headquartered in the US in San Francisco and internationally in Berlin, Caresyntax software is used in over 4,200 ORs globally and aids surgical teams in over 3 million procedures annually. To learn more about how we’re transforming surgical care, visit us at www.caresyntax.com.